Visual Inspection Particulates Injectables
Every parenteral unit must be inspected for visible particulates and container/closure defects before release. USP <790> sets the binary release criterion (essentially free of visible particulates), USP <1790> sets the inspection methodology, and PDA TR-79 + Annex 1 (2022) define the manual + semi-automatic + fully automated inspection programmes that operationalise it.
Read the full summary
Inspection regime hinges on lighting (2000-3750 lux at the inspection point), background contrast (matte black + matte white), unit handling (swirl + invert sequence), inspector qualification (per-shift acuity testing + per-defect Knapp test), and rejection categories (critical / major / minor). AQL-driven sampling for routine release, automated inspection systems for high-volume products, and a Knapp test programme that links operator + system performance to particle-detection probability are the operational pillars of a defensible inspection programme.
On this page · 8 sections
- 1USP <790> — the binary release criterion
- 2Inspection conditions — lighting, background, viewing time
- 3Defect categories — critical / major / minor
- 4Inspector qualification + the Knapp test
- 5Automated inspection — Eisai / Bosch / Brevetti machines
- 6Particulate investigation + source classification
- 7Common failure modes
- 8How V5 Ultimate runs visual inspection
How does Visual Inspection Particulates Injectables apply to your shop floor?
Pick your industry and scale — Ask V5 rewrites the definition in your context, gives a worked example, and shows what V5 does on day one.
01USP <790> — the binary release criterion
USP <790> requires that each unit of parenteral product be 'essentially free' of visible particulates when inspected under prescribed lighting conditions. The standard does not give a numerical limit. Instead it sets a methodology + an AQL-based sampling plan (typically AQL 0.65 for critical defects, AQL 1.0-1.5 for major). Every unit is 100% inspected during manufacture; a statistical re-inspection or AQL sample is taken from finished batches for release confirmation. 'Essentially free' is operationally defined by the inspection conditions — what is visible to a qualified inspector under standard conditions IS a defect; what is not visible is not.
02Inspection conditions — lighting, background, viewing time
| Parameter | USP <1790> requirement | Comment |
|---|---|---|
| Illumination at inspection point | 2,000 - 3,750 lux (200 - 375 ft-cd) | Measured at the unit, not at the lamp; calibrated lux meter |
| Background | Matte black + matte white (alternating) | Black background reveals translucent particles; white reveals dark particles |
| Viewing time per unit | 5 - 10 seconds per background = 10-20 seconds total | Insufficient time = false negatives; common operator deviation |
| Container handling | Swirl, invert, and tilt to suspend particles in liquid + check meniscus + cake | Static inspection misses settled particles |
| Inspector posture + distance | Comfortable distance (typically 25-35 cm); rest breaks; rotation | Fatigue degrades detection sensitivity |
| Acuity testing | Per-shift near-vision check; corrected to 20/30 or better | Vision degrades through the day |
03Defect categories — critical / major / minor
| Category | Examples | AQL |
|---|---|---|
| Critical | Foreign particles ≥ 100 µm, broken / cracked container, missing closure, container leak | AQL 0.10 - 0.65 typical |
| Major | Discolouration, fill volume out of spec, label legibility issue, container surface defect | AQL 1.0 - 1.5 typical |
| Minor | Cosmetic blemish, minor label imperfection | AQL 2.5 - 4.0 typical |
04Inspector qualification + the Knapp test
- Initial training — theoretical (USP <790>/<1790> + product defect catalogue) + practical (mentored inspection of known defect sets);
- Initial qualification — Knapp test on a defect-seeded test set; per-defect detection probability ≥ pre-defined threshold (often ≥ 70% per defect, ≥ 95% per defect-type panel);
- Re-qualification — typically annual + after any extended absence; same Knapp methodology;
- Per-shift acuity check — near-vision card or equivalent; documented;
- Rotation + breaks — typical 30-60 minute rotation off the line to maintain detection sensitivity;
- Detection-probability tracking — per-inspector trend over time; downward drift triggers re-qualification.
05Automated inspection — Eisai / Bosch / Brevetti machines
High-volume products typically run on automated inspection systems (Eisai, Bosch, Brevetti, Stevanato) that use rotating-spindle illumination + multi-camera vision systems + specialised algorithms (moving-particle detection, shadow-detection, fill-level, cosmetic). Automated systems are qualified per the Knapp test methodology: a defect-seeded set is presented to the machine + to a panel of qualified manual inspectors; the machine's per-defect detection probability is compared and required to be statistically non-inferior. Periodic re-qualification + per-shift challenge set + per-batch sampling for confirmation are routine.
06Particulate investigation + source classification
- Every rejected unit category-tracked + trended by SPC; rising trend triggers investigation;
- Particulate-source identification — FTIR / SEM-EDX / Raman to characterise particle type (glass, stopper rubber, gowning fibre, API agglomerate, environmental contamination);
- Cross-reference to upstream process — glass from vial manufacture / wash, stopper fragment from coring, fibre from gowning, API agglomerate from formulation;
- CAPA — process correction, equipment intervention, supplier action (e.g. tighter glass-vial CoA), gowning review;
- Inspection effectiveness review — was the trend missed at line? Was Knapp-based threshold appropriate?
07Common failure modes
- Lighting below 2,000 lux at the inspection point — measured at lamp not at unit; common audit-finding.
- Inspectors inspecting > 10 seconds per background but counting once — fatigue then degrades subsequent units.
- No swirl / no invert — static inspection misses settled and trapped-in-meniscus particles.
- Knapp test seeded with only easy-to-see particles — qualification artificially passes; commercial detection low.
- Per-shift acuity check skipped — declining inspector vision goes undetected.
- Rotation skipped on rush batches — fatigued operators on critical product.
- Automated-system threshold tightened to reduce false rejects, with no Knapp re-qualification — true defects also missed.
- Defect catalogue not updated as new commercial defect types emerge — operator sees a new defect and does not know how to classify.
- AQL sample drawn from one position only — non-representative; positional defect concentration missed.
- Investigation closure 'attributed to particulate from environment' without source-identification — recurrence not prevented.
08How V5 Ultimate runs visual inspection
- Per-product defect catalogue: photographic reference + category (critical/major/minor) + AQL + change-control;
- Inspector register: training + Knapp-test results + per-defect detection probability + per-shift acuity check + rotation log;
- Inspection-station configuration: light meter result + background colour + viewing time SOP + auto-block on lighting deviation;
- Per-unit defect capture: barcode-scan + tablet-or-button defect category capture; auto-tally per AQL plan;
- Automated-system integration: per-unit machine result + Knapp-test history + per-batch challenge-set log;
- AQL-release decision: per-batch tally vs AQL plan; auto-pass / auto-fail with per-defect-category breakdown;
- Particulate-source investigation: link to upstream batch + supplier + environmental + gowning context; CAPA wiring;
- Trend dashboard: per-product per-defect-type SPC; per-inspector + per-line + per-shift performance;
- Inspection pack: per-batch inspection record + inspector qualification + acuity check + AQL decision — exports as one PDF.
Frequently asked questions
Q.Is USP <790> a numerical particle-count standard?+
No — it is a methodology + binary release criterion. The numerical particle-count standard for sub-visible particles is USP <788> (≥ 10 µm and ≥ 25 µm limits per unit). USP <790> covers visible particles, defined operationally by inspection conditions, and demands 'essentially free' with AQL sampling.
Q.What's the Knapp test?+
A statistical inspection-effectiveness test developed by Knapp + Kushner (1980). The same defect-seeded set is inspected multiple times (typically 10×) by multiple inspectors; per-particle detection probability is calculated. Used for inspector qualification, automated-system qualification, and inspection-condition optimisation. Industry-standard for the past 40+ years.
Q.Can we use a single matte-grey background instead of black + white?+
Not USP-compliant — <1790> explicitly requires alternating black + white because particle types differ in visibility against each. Some sites use grey for an additional inspection pass, but the black + white pair is the regulatory baseline.
Q.What about coloured or opaque products?+
Inspection sensitivity drops significantly. For opaque products (suspensions, lipid emulsions, lyophilised cake before reconstitution), visual inspection is limited to container/closure + cake appearance + fill. Particulate detection in suspension is augmented by post-reconstitution inspection or process-controls upstream.
Q.Are automated systems required for new products?+
Not required, but increasingly the default for high-volume parenterals. Annex 1 (2022) §8.30 + FDA expectation favours automated systems for repetitive inspection at scale; manual inspection retained for low-volume, specialty, or AQL re-inspection.
Q.What's the relationship between visible + sub-visible particulate testing?+
Complementary. <790> + <1790> govern visible particulates (≥ ~50 µm, depending on conditions). <788> governs sub-visible (≥ 10 µm + ≥ 25 µm cumulative limits per unit). Both apply to all parenterals; control strategy addresses both ranges and identifies particulate source across the full size distribution.
Primary sources
- USP <790> Visible Particulates in Injections
- USP <1790> Visual Inspection of Injections
- USP <788> Particulate Matter in Injections (sub-visible)
- EP 2.9.20 Particulate Contamination — Visible Particles
- PDA Technical Report 79 — Particulate Matter Control in Injectables
- EU GMP Annex 1 (2022) §8.30 — Visual inspection
- 21 CFR 211.165(b) — Sterility + impurity testing for product release
Further reading
- USP <788> Particulate Matter (sub-visible)10 µm + 25 µm sub-visible particulate framework.
- AQL SamplingAcceptable Quality Level sampling plans for batch release.
- EU GMP Annex 1Sterile-manufacture umbrella covering visual inspection.
- Extractables & LeachablesContainer-closure-derived particulate sources.
Want to see how Visual Inspection Particulates Injectables could fit into your own records and workflows? Explore the related V5 pages or talk to our team about what applies to your operation.
